Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NRX Pharmaceuticals (NRXP) FCF Margin (2024 - 2025)

NRX Pharmaceuticals (NRXP) has disclosed FCF Margin for 2 consecutive years, with 377.62% as the latest value for Q4 2025.

  • Quarterly FCF Margin changed N/A to 377.62% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1152.0% through Dec 2025, down 577678.0% year-over-year, with the annual reading at 1152.0% for FY2025, N/A changed from the prior year.
  • FCF Margin for Q4 2025 was 377.62% at NRX Pharmaceuticals, up from 1195.04% in the prior quarter.
  • The five-year high for FCF Margin was 1596.09% in Q1 2024, with the low at 1195.04% in Q3 2025.